Newton biotech's drug for hot flashes due to menopause fails trial

Shares of the company plummeted 40% after the results of a midstage clinical trial were announced.

Source: bizjournals.com Health Care:Biotechnology headlines - March 17, 2023 Category: Biotechnology Authors: Rowan Walrath Source Type: news